Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KRT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KRT77 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT73 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT72 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT76 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT74 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
KRT71 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT79 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT78 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT6A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT6C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on